Australian Clinical Labs (ASX:ACL) said the Commonwealth Bank of Australia's (ASX:CBA) voting power in the company rose to 8.31% from 7.29% as of May 22, according to a Monday Australian bourse filing.
The bank now holds 15.6 million ordinary shares of the firm.